Aspirin resistance and diabetes mellitus

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609 · see citing works

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943 · see citing works

The way I see it: House officers need formal career development

Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,146 · see citing works

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Gum, P. A., Kottke‐Marchant, K., Poggio, E. D., Gurm, H. S., Welsh, P. A., Brooks, L. M., Sapp, S. K., & Topol, E. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01631-9 · Cited by 818 · see citing works

Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease

Hirsh, P. D., Hillis, L. D., Campbell, W. B., Firth, B. G., & Willerson, J. T. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103193041201 · Cited by 593 · see citing works

Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed

Collet, J. ‐., Park, D., Lesty, C., Soria, J., Soria, C., Montalescot, G., & Weisel, J. W. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1354 · Cited by 492 · see citing works

Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus

Kassoff, A. (1992) · JAMA · doi:10.1001/jama.1992.03490100090033 · Cited by 479 · see citing works

Clinical pharmacology of platelet cyclooxygenase inhibition.

Patrono, C., Ciabattoni, G., Patrignani, P., Pugliese, F. R., Filabozzi, P., Catella, F., Davı̀, G., & Forni, L. (1985) · Circulation · doi:10.1161/01.cir.72.6.1177 · Cited by 454 · see citing works

Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.

Willerson, J. T., Golino, P., Eidt, J. F., Campbell, W. B., & Buja, L. M. (1989) · Circulation · doi:10.1161/01.cir.80.1.198 · Cited by 453 · see citing works

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02567-5 · Cited by 409 · see citing works

Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients

Sacco, M., Pellegrini, F., Roncaglioni, M. C., Avanzini, F., Tognoni, G., Nicolucci, A., & on behalf of the PPP Collaborative Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3264 · Cited by 381 · see citing works

Phospholipase A2: Function and pharmacological regulation

CHANG, J. Y., Musser, J. H., & McGregor, H. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90512-0 · Cited by 342 · see citing works

Proneness to Formation of Tight and Rigid Fibrin Gel Structures in Men with Myocardial Infarction at a Young Age

Fatah, K., Silveira, A. M. V., Tornvall, P., Karpe, F., Blombäck, M., & Hamsten, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650618 · Cited by 221 · see citing works

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

Schwartz, K. A., Schwartz, D. E., Ghosheh, K., Reeves, M. J., Barber, K. R., & DeFranco, A. C. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.038 · Cited by 210 · see citing works

Aspirin Resistance and Atherothrombotic Disease

Mason, P. J., Jacobs, A. K., & Freedman, J. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.070 · Cited by 209 · see citing works

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)—its relation to metabolic control

Watała, C. W., Golański, J., Pluta, J., Boncler, M. A., Różalski, M., Luzak, B., Kropiwnicka, A., & Drzewoski, J. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2003.12.016 · Cited by 192 · see citing works

Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism

Undas, A., Sydor, W., Brummel, K. E., Musiał, J., Mann, K. G., & Szczeklik, A. (2003) · Circulation · doi:10.1161/01.cir.0000047062.03282.a3 · Cited by 189 · see citing works

In vitro Acetylation of Plasma Proteins, Enzymes and DNA by Aspirin

Pinckard, R. N., Hawkins, D., & Farr, R. S. (1968) · Nature · doi:10.1038/219068a0 · Cited by 187 · see citing works

Biology and Pharmacology of the Platelet P2Y12 Receptor

Storey, R. F. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776361318 · Cited by 179 · see citing works

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

Dunn, E. J., Philippou, H., Ariëns, R. A. S., & Grant, P. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0197-4 · Cited by 177 · see citing works

Narrative Review: Aspirin Resistance and Its Clinical Implications

Sanderson, S., Emery, J. D., Baglin, T. P., & Kinmonth, A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00012 · Cited by 160 · see citing works

Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.

Roth, G. J., & Siok, C. J. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34756-7 · Cited by 147 · see citing works

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

Watała, C. W., Pluta, J., Golański, J., Różalski, M., Czyż, M., Trojanowski, Z., & Drzewoski, J. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0600-x · Cited by 136 · see citing works

Review article: gastrointestinal bleeding with low‐dose aspirin – what's the risk?

Laine, L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03077.x · Cited by 131 · see citing works

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Ohmori, T., Yatomi, Y., NONAKA, T., Kobayashi, Y., Madoiwa, S., Mimuro, J., Ozaki, Y., & Sakata, Y. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01958.x · Cited by 121 · see citing works

Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003

Cubbon, R. M., Wheatcroft, S. B., Grant, P. J., Gale, C. P., Barth, J. H., Sapsford, R. J., Ajjan, R., Kearney, M. T., Hall, A. S., & on behalf of the EMMACE (Evaluation of Methods and Management of Acute Coronary Events) Investigators (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl510 · Cited by 118 · see citing works

Coagulation and atherothrombotic disease

Ajjan, R., & Grant, P. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.042 · Cited by 106 · see citing works

Prevalence of aspirin resistance in patients with type 2 diabetes

Fateh‐Moghadam, S., Plöckinger, U., Cabeza, N., Htun, P., Reuter, T., Ersel, S., Gawaz, M., Dietz, R., & Bocksch, W. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0186-y · Cited by 104 · see citing works

Measurement of Thrombin Generation in Whole Blood - The Effect of Heparin and Aspirin

Kessels, H., Beguı́n, S., Andree, H. A. M., & Hemker, H. C. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648815 · Cited by 103 · see citing works

The collagen-platelet interaction

Barnes, M. J., Knight, C. G., & Farndale, R. W. (1998) · Current Opinion in Hematology · doi:10.1097/00062752-199809000-00002 · Cited by 93 · see citing works

Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteers

Fontana, P., Nolli, S., Reber, G., & de Moerloose, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01867.x · Cited by 89 · see citing works

Trial of repeated low-dose aspirin in diabetic angiopathy

DiMinno, G., Silver, M., Cerbone, A. M., & Murphy, S. (1986) · Blood · doi:10.1182/blood.v68.4.886.886 · Cited by 87 · see citing works

Dependence of Human Platelet Functional Responses on Divalent Cations: Aggregation and Secretion in Heparin- and Hirudin-Anticoagulated Platelet-Rich Plasma and the Effects of Chelating Agents

Lages, B. A., & Weiss, H. J. (1981) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650158 · Cited by 86 · see citing works

AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions

Nicolucci, A., Berardis, G. D., Sacco, M., & Tognoni, G. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm248 · Cited by 68 · see citing works

Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid

Williams, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1088 · Cited by 62 · see citing works

Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.

Watała, C. W., Boncler, M. A., & Grešner, P. (2005) · PubMed · Cited by 60 · see citing works

Prevention of cardiovascular disease in type-2 diabetes: How to improve the clinical efficacy of aspirin

Totani, L., Rotondo, S., Lorenzet, R., Tognoni, G., Berardis, G. D., Nicolucci, A., & Evangelista, V. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-07-0453 · Cited by 58 · see citing works

Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo.

Rendell, M., Nierenberg, J., Brannan, C., Valentine, J. L., Stephen, P. M., Dodds, S. J., Mercer, P., Smith, P. K., & Walder, J. A. (1986) · PubMed · Cited by 56 · see citing works

Comparison of Aspirin Resistance in Type 1 Versus Type 2 Diabetes Mellitus

Mehta, S., Silver, R., Aaronson, A. G., Abrahamson, M. J., & Goldfine, A. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.093 · Cited by 55 · see citing works

Marked increase of fibrin gel permeability with very low dose ASA treatment

Antovič, A., Perneby, C., Ekman, G. J., Wallén, H., Hjemdahl, P., Blombäck, M., & He, S. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.02.007 · Cited by 55 · see citing works

Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man

Küster, L., & Frölich, J. C. (1986) · Prostaglandins · doi:10.1016/0090-6980(86)90009-2 · Cited by 54 · see citing works

Modified Clotting Properties of Fibrinogen in the Presence of Acetylsalicylic Acid in a Purified System

He, S., Blombäck, M., Yoo, G., SINHA, R., & Henschen-Edman, A. H. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03540.x · Cited by 42 · see citing works

Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin

Takahashi, S., Ushida, M., Komine, R., Shimizu, A., Uchida, T., Ishihara, H., Shibano, T., Watanabe, G., Ikeda, Y., & Murata, M. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.04.004 · Cited by 41 · see citing works

Acetyl- l -Carnitine Decreases Glycation of Lens Proteins: in vitro Studies

Swamy-Mruthinti, S., & Carter, A. L. (1999) · Experimental Eye Research · doi:10.1006/exer.1999.0680 · Cited by 38 · see citing works

High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study

Watała, C. W., Uličná, O., Golański, J., Nocun, M., Waczulı́ková, I., Markuszewski, L., & Drzewoski, J. (2006) · Blood Coagulation & Fibrinolysis · doi:10.1097/01.mbc.0000203862.85610.ac · Cited by 25 · see citing works

Effects of aspirin for primary prevention in persons with diabetes mellitus

The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804988 · Cited by 1,189 · see citing works

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index<subtitle>A Randomized Controlled Trial</subtitle>

Fowkes, F. G. R. (2010) · JAMA · doi:10.1001/jama.2010.221 · Cited by 624 · see citing works

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

De Berardis, G., Sacco, M., Strippoli, G. F. M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009) · BMJ · doi:10.1136/bmj.b4531 · Cited by 395 · see citing works

Review article: Coagulation and fibrinolysis in diabetes

Alzahrani, S. H., & Ajjan, R. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110383723 · Cited by 231 · see citing works

Critical Reviews in Clinical Laboratory Sciences

Linden, M. D., & Tran, H. A. (2012) · Cited by 217 · see citing works

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis

Zhang, C., Sun, A., Zhang, P., Wu, C., Zhang, S., Fu, M., Wang, K., Zou, Y., & Ge, J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.029 · Cited by 150 · see citing works

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis

de Vries, J. J., Snoek, C. J. M., Rijken, D. C., & de Maat, M. P. M. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313626 · Cited by 134 · see citing works

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Dragani, A., Pascale, S., Recchiuti, A., Mattoscio, D., Lattanzio, S., Petrucci, G., Mucci, L., Ferrante, E., Habib, A., Ranelletti, F. O., et al. (2009) · Blood · doi:10.1182/blood-2009-08-236679 · Cited by 113 · see citing works

Role of Fibrin Structure in Thrombosis and Vascular Disease

Corte, A. L. C. L., Philippou, H., & Ariëns, R. A. S. (2011) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-381262-9.00003-3 · Cited by 88 · see citing works

The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?

Porter, K. E., & Riches‐Suman, K. (2013) · Clinical Science · doi:10.1042/cs20120413 · Cited by 85 · see citing works

Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis

Konieczyńska, M., Fil, K., Bazanek, M., & Undas, A. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0566 · Cited by 76 · see citing works

Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus

MORTENSEN, S. B., Larsen, S., Grove, E. L., Kristensen, S. D., & Hvas, A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.03.013 · Cited by 67 · see citing works

Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: A mass spectrometric and isotope labeling study

Svensson, J. E., Bergman, A., Adamson, U., Blombäck, M., Wallén, H., & Jörneskog, G. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.154 · Cited by 58 · see citing works

The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

Neergaard‐Petersen, S., Hvas, A., Kristensen, S. D., Grove, E. L., Larsen, S., Phoenix, F. A., Kurdee, Z., Grant, P. J., & Ajjan, R. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-05-0468 · Cited by 58 · see citing works

Aspirin for primary prevention of cardiovascular and all‐cause mortality events in diabetes: updated meta‐analysis of randomized controlled trials

Kunutsor, S. K., Seidu, S., & Khunti, K. K. (2016) · Diabetic Medicine · doi:10.1111/dme.13133 · Cited by 58 · see citing works

Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives

Sander, D., & Kearney, M. T. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5143-1 · Cited by 52 · see citing works

Effect of Aspirin Dose on Mortality and Cardiovascular Events in People with Diabetes: A Meta-Analysis

Simpson, S. H., Gamble, J., Mereu, L., & Chambers, T. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1757-y · Cited by 42 · see citing works

The potential of anthocyanin-rich Queen Garnet plum juice supplementation in alleviating thrombotic risk under induced oxidative stress conditions

Santhakumar, A. B., Kundur, A., Sabapathy, S., Stanley, R. A., & Singh, I. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.003 · Cited by 36 · see citing works

High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets

Russo, I., Viretto, M., Barale, C., Mattiello, L., Doronzo, G., Pagliarino, A., Cavalot, F. L., Trovati, M., & Anfossi, G. (2012) · Diabetes · doi:10.2337/db12-0040 · Cited by 36 · see citing works

Aspirin in primary prevention for patients with diabetes: Still a matter of debate

Bonaventura, A., Liberale, L., & Montecucco, F. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13001 · Cited by 34 · see citing works

Diabetes mellitus and the heart

Mercer, B. N., Morais, S. R. D. L. O. K., Cubbon, R. M., & Kearney, M. T. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02924.x · Cited by 33 · see citing works

Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes

Christensen, K. H., Grove, E. L., Würtz, M., Kristensen, S. D., & Hvas, A. (2014) · Platelets · doi:10.3109/09537104.2014.901497 · Cited by 33 · see citing works

Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment

Mathewkutty, S., & McGuire, D. K. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.30 · Cited by 26 · see citing works

The flavonols quercetin and 3′,4′-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes

Mosawy, S., Jackson, D. E., Woodman, O. L., & Linden, M. D. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114524234 · Cited by 25 · see citing works

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove, E. L. (2012) · PubMed · Cited by 24 · see citing works

The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin

Neergaard‐Petersen, S., Hvas, A., Grove, E. L., Larsen, S. B., Gregersen, S., & Kristensen, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132629 · Cited by 24 · see citing works

Frequency, Risk Factors, Prognosis, and Genetic Polymorphism of the Cyclooxygenase-1 Gene for Aspirin Resistance in Elderly Chinese Patients with Cardiovascular Disease

Fan, L., Cao, J. J., Liu, L., Li, X., Hu, G., Hu, Y., & Zhu, B. (2012) · Gerontology · doi:10.1159/000342489 · Cited by 24 · see citing works

Antiplatelet therapy and vascular disease: an update

Buch, M. H., Prendergast, B., & Storey, R. F. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710375780 · Cited by 22 · see citing works

Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study

Welin, L., Wilhelmsen, L., Björnberg, A., & Odén, A. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1828 · Cited by 22 · see citing works

Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs

Tufano, A., Cimino, E., Minno, M. N. D. D., Ieranò, P., Marrone, E., Strazzullo, A., Minno, G. D., & Cerbone, A. M. (2011) · International Journal of Vascular Medicine · doi:10.1155/2011/250518 · Cited by 21 · see citing works

Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes

Harrison, P., Bethel, M. A., Kennedy, I., Dinsdale, R. J., Coleman, R. L., & Holman, R. R. (2018) · Platelets · doi:10.1080/09537104.2018.1478402 · Cited by 20 · see citing works

Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia

Barale, C., Cavalot, F. L., Frascaroli, C., Bonomo, K., Morotti, A., Guerrasio, A., & Russo, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144983 · Cited by 19 · see citing works

Adding Pharmacists to Primary Care Teams Increases Guideline-Concordant Antiplatelet Use in Patients with Type 2 Diabetes: Results from a Randomized Trial

Gilani, F., Majumdar, S. R., Johnson, J. A., Tsuyuki, R. T., Lewanczuk, R. Z., Spooner, R., & Simpson, S. H. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r552 · Cited by 19 · see citing works

Exploring Mechanisms of Graft Occlusion

Storey, R. F. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.065 · Cited by 16 · see citing works

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets

Sagar, R. C., Ajjan, R., & Naseem, K. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094973 · Cited by 14 · see citing works

Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes

Rhee, T., Bae, J., Park, K. W., Rha, S., Kang, J., Lee, H., Yang, H., Kwak, S., Chae, I., Shin, W., et al. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.0592 · Cited by 14 · see citing works

Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.

Astrup, A. S. (2011) · PubMed · Cited by 14 · see citing works

Potential regulatory role of calsequestrin in platelet Ca2+ homeostasis and its association with platelet hyperactivity in diabetes mellitus

Zhu, Z., Zhou, H., Yu, X., Chen, L., Zhang, H., Ren, S., Wu, Y., & Luo, D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04550.x · Cited by 13 · see citing works

The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease

Cao, J. J., Liu, L., Fan, L., Chen, T., Hu, G., Hu, Y., Zhu, B., Li, J., Wang, H., & Li, X. (2012) · The Aging Male · doi:10.3109/13685538.2012.666584 · Cited by 13 · see citing works

Prevalence and Risk Factors for Aspirin Resistance in Elderly Patients With Type 2 Diabetes

Liu, L., Cao, J. J., Li, F., Hu, G., Hu, Y., Zhu, B., Li, X., Wang, H., Bai, J., & Shi, H. (2011) · International journal of gerontology · doi:10.1016/j.ijge.2011.04.016 · Cited by 12 · see citing works

Overcoming aspirin treatment failure in diabetes

Linden, M. D., & Tran, H. A. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.731377 · Cited by 12 · see citing works

Evaluation of low-dose aspirin for primary prevention of ischemic stroke among patients with diabetes: a retrospective cohort study

Kim, Y., Choi, N., Kim, M., Lee, J., Chang, Y., Seong, J.-M., Jung, S., Shin, J., Park, J., & Park, B. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0002-y · Cited by 10 · see citing works

Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid

Bryk, A. H., Zettl, K., Wiśniewski, J. R., & Undas, A. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.11.031 · Cited by 9 · see citing works

Aspirin in type 2 diabetes: is there any evidence base?

Walsh, M., & Spurling, G. (2008) · BMJ · doi:10.1136/bmj.a1902 · Cited by 9 · see citing works

Aspirin as antiplatelet agent in diabetes. PROS-

Davı̀, G., & Santilli, F. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.03.008 · Cited by 9 · see citing works

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

Parker, W. A., Sagar, R. C., Kurdee, Z., Hawkins, F., Naseem, K. M., Grant, P. J., Storey, R. F., & Ajjan, R. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01427-y · Cited by 7 · see citing works

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence

Dimitriadis, K. S., Lazarou, E., Tsioufis, P., Σουλαϊδόπουλος, Σ., & Tsioufis, K. P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01740-2 · Cited by 7 · see citing works

Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus

Younis, N., Williams, S. D., & Soran, H. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01068.x · Cited by 7 · see citing works

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin

Vonkeman, H. E. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s7206 · Cited by 6 · see citing works

Aspirin Use Rates in Diabetes: A Systematic Review Cross-Sectional Study

Law, E. H., & Simpson, S. H. (2010) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(10)43009-9 · Cited by 6 · see citing works

Altered platelet calsequestrin abundance, Na+/Ca2+ exchange and Ca2+ signaling responses with the progression of diabetes mellitus

Zheng, Y., Wang, L., Zhu, Z., Yan, X., Zhang, L., Xu, P., & Luo, D. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.056 · Cited by 6 · see citing works

Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

Randriamboavonjy, V. (2015) · InTech eBooks · doi:10.5772/60539 · Cited by 6 · see citing works

Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project

Milionis, H. J., Ntaios, G., Papavasileiou, V., Spengos, K. M., Manios, E. D., Elisaf, M., & Vemmos, K. N. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.06.052 · Cited by 6 · see citing works

Interventions for Coronary Artery Disease (Surgery vs Angioplasty) in Diabetic Patients

Hoffman, D. M., & Tranbaugh, R. F. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.011 · Cited by 5 · see citing works

Interaction of glycated and acetylated human α2-antiplasmin with fibrin clots

Bryk, A. H., Satała, D., Natorska, J., Rąpała‐Kozik, M., & Undas, A. (2020) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000935 · Cited by 5 · see citing works

Establishing a predictive model for aspirin resistance in elderly Chinese patients with chronic cardiovascular disease.

Cao, J. J., Hao, W., Gao, L.-G., Chen, T.-M., Liu, L., Sun, Y., Hu, G., Hu, Y., & Li, F. (2016) · PubMed Central · doi:10.11909/j.issn.1671-5411.2016.05.003 · Cited by 5 · see citing works

Identification of glycated and acetylated lysine residues in human α2-antiplasmin

Bryk, A. H., Cysewski, D., Dadlez, M., & Undas, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.144 · Cited by 4 · see citing works

Drug Resistance in Diabetes

Khaliq, A., Chughtai, M. F. J., Javed Iqbal, M., Nawaz, H., Ahsan, S., Mehmood, T., Liaqat, A., Nadeem, M., Sameed, N., Saeed, K., et al. (2021) · Springer eBooks · doi:10.1007/978-3-030-76320-6_16 · Cited by 4 · see citing works

Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial

Uriel, N., Netuka, I., Jorde, U. P., Pagani, F. D., Katz, J. N., Connors, J. M., Ivák, P., Zimpfer, D., Pya, Y., Conway, J. L., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.11.488 · Cited by 3 · see citing works

Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease

Hong, S., Lee, W. J., & Park, C.-Y. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1353 · Cited by 3 · see citing works

Le concept de « résistance » à l’aspirine : mécanismes et pertinence clinique

Reny, J., Bonvini, R. F., Barazer, I., Berdagué, P., de Moerloose, P., Schved, J., Gris, J., & Fontana, P. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.02.028 · Cited by 3 · see citing works

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?

Göktürk, I. K., Özünal, I. E., Göktürk, A., HAKAN, K. A., YILMAZ, G., Akay, O. M., & Öztürk, E. (2023) · Turkish Journal of Hematology · doi:10.4274/tjh.galenos.2023.2022.0452 · Cited by 3 · see citing works

Coronary artery bypass graft (CABG) and the diabetic patient: current perspectives

Hoffman, D. M., & Tranbaugh, R. F. (2014) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s39994 · Cited by 2 · see citing works

Measurement of platelet function to determine the prevalence of aspirin non-responsiveness among Saudi type II diabetic patients

Albanyan, A., Alahmari, S., Alayed, K. M., Malik, A., Gader, A. G. M. A., & Al‐Shaikh, Y. (2016) · Journal of Health Specialties · doi:10.4103/1658-600x.173837 · Cited by 2 · see citing works

Serum uric acid level negatively correlated with the prevalence of clopidogrel low response in patients undergoing antiplatelet treatment with aspirin and clopidogrel

Wang, J., Abdus, S., Tan, C., Gu, Q., Yang, M., Wang, G., Shi, L., Gong, X., & Li, C. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.025 · Cited by 2 · see citing works

What drives thrombogenesis despite antiplatelet therapy in diabetes mellitus?

Storey, R. F. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110388196 · Cited by 2 · see citing works

Antiplatelet Loading Effects Prior to Endovascular Treatment: Carotid Artery Stenosis versus Unruptured Cerebral Aneurysms

Amari, K., Sugawara, E., Yamamoto, R., Amano, Y., Yamamoto, M., & Johkura, K. (2021) · Journal of Neuroendovascular Therapy · doi:10.5797/jnet.oa.2019-0125 · Cited by 1 · see citing works

The Diabetic Platelet

Neokleous, N., Stavroula, M., & Perifanis, V. (2022) · Journal of Family Medicine · doi:10.26420/jfammed.2022.1312 · Cited by 1 · see citing works

Does the fat cell have something to say to the platelet about keeping thrombosis in check in diabetes?

Lane, J. T. (2011) · Translational research · doi:10.1016/j.trsl.2011.08.011 · Cited by 1 · see citing works

Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial

Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., Chen, Y., Thompson, J. L. P., Homma, S., Lip, G. Y. H., et al. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03544-4 · Cited by 1 · see citing works

Assessment of platelet aspirin responsiveness in Turkish Population with PFA-100, serum thromboxane B2, soluble CD40 ligand and soluble P-Selectin

Saka, B., Genç, S., Eroğlu, H., Akpınar, T. S., Karadaǧ, A., Kılıç, L., Erten, N., Taşçıoğlu, C., & Omer, B. (2013) · Turkish Journal of Biochemistry · doi:10.5505/tjb.2013.75437 · Cited by 1 · see citing works

The effect of the flavonols quercetin and 3', 4' dihydroxyflavonol on platelet function in vitro and in vivo

Mosawy, S. (2013) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27580971

To Analyze the Adverse Drug Reaction of Asprin and Clopidogrel during the Treatment for Platelet Aggregation

黄, 之. (2015) · Medical Diagnosis · doi:10.12677/md.2015.53006

Aspirin in diabetes mellitus: mechanisms and clinical implications

Kurdee, Z. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

Role of Antioxidants and Polyphenols in Thrombosis and Haemostatic Function

Santhakumar, A. B. (2014) · Griffith Research Online · doi:10.25904/1912/1314

ANTITHROBOCYTIC THERAPY IN CORRECTION OF COAGULATION DISORDERS IN TYPE 2 DIABETES MELLITUS

Yefimov, A. S., & Shuliarenko, L. V. (2010) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2010.3.02

Aspirin Resistance Among Patients with Recurrent Ischaemic Stroke, and Outcome of Patients at 120 Days with Alternative Antiplatelet: A Cohort Study in a Tertiary Care Hospital in Bangladesh

Sayeed, S. K. J. B., Moniruzzaman, M., Mahmud, R., Kamal, M. M., Das, S. C., Rashid, M. B., Hossain, S. K. M. R., Rahman, S. B., Yusuf, M. A., Alam, M. B., et al. (2025) · Journal of Stroke Medicine · doi:10.1177/25166085251327817

Additional file 1 of A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

Parker, W. A. E., Sagar, R. C., Kurdee, Z., Hawkins, F., Naseem, K. M., Grant, P. J., Storey, R. F., & Ajjan, R. A. (2021) · Figshare · doi:10.6084/m9.figshare.17273244

Aspirin and fibrin clot modulation in vascular pharmacology: Fibrinogen acetylation, disease context, and translational uncertainty

Nerini, A., Nencini, F., Borghi, S., Giurranna, E., Taddei, N., Fiorillo, C., & Becatti, M. (2026) · Vascular Pharmacology · doi:10.1016/j.vph.2026.107677

Diabetes and Aspirin Resistance

Yaturu, S., & Mous, S. A. (2011) · InTech eBooks · doi:10.5772/20605 · Cited by 2 · see citing works

Aspirin and clopidogrel resistance in patients with diabetes mellitus

Scheen, A. J., & Legrand, D. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl295 · Cited by 14 · see citing works

Research progress of aspirin resistance in diabetic statue

Ha, X. (2014) · Zhongguo linchuang yaolixue yu zhiliaoxue

A case of aspirin-resistance probably related to glycemic excursion

Fava, I., Marfella, R., Paolisso, G., & Rizzo, M. R. (2010) · Clinical Management Issues · doi:10.7175/cmi.v4i4.520

Overcoming aspirin treatment failure in diabetes

Linden, M. D., & Tran, H. A. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.731377 · Cited by 12 · see citing works